Logo image of ASA.OL

ATLANTIC SAPPHIRE ASA (ASA.OL) Stock Fundamental Analysis

OSL:ASA - Oslo Bors ASA - NO0013249896 - Common Stock - Currency: NOK

12.298  -0.4 (-3.17%)

Fundamental Rating

3

Overall ASA gets a fundamental rating of 3 out of 10. We evaluated ASA against 60 industry peers in the Food Products industry. ASA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ASA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ASA had negative earnings in the past year.
ASA had a negative operating cash flow in the past year.
ASA had negative earnings in each of the past 5 years.
ASA had a negative operating cash flow in each of the past 5 years.
ASA.OL Yearly Net Income VS EBIT VS OCF VS FCFASA.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 -20M -40M -60M -80M -100M

1.2 Ratios

With a Return On Assets value of -41.83%, ASA is not doing good in the industry: 94.74% of the companies in the same industry are doing better.
The Return On Equity of ASA (-51.90%) is worse than 91.23% of its industry peers.
Industry RankSector Rank
ROA -41.83%
ROE -51.9%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ASA.OL Yearly ROA, ROE, ROICASA.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 -10 -20 -30 -40 -50

1.3 Margins

ASA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ASA.OL Yearly Profit, Operating, Gross MarginsASA.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 -500 -1K -1.5K -2K

More info and screens

5

2. Health

2.1 Basic Checks

ASA does not have a ROIC to compare to the WACC, probably because it is not profitable.
ASA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ASA.OL Yearly Shares OutstandingASA.OL Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M
ASA.OL Yearly Total Debt VS Total AssetsASA.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M

2.2 Solvency

ASA has an Altman-Z score of 70.38. This indicates that ASA is financially healthy and has little risk of bankruptcy at the moment.
ASA's Altman-Z score of 70.38 is amongst the best of the industry. ASA outperforms 100.00% of its industry peers.
A Debt/Equity ratio of 0.15 indicates that ASA is not too dependend on debt financing.
The Debt to Equity ratio of ASA (0.15) is better than 92.98% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z 70.38
ROIC/WACCN/A
WACC8.26%
ASA.OL Yearly LT Debt VS Equity VS FCFASA.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M

2.3 Liquidity

A Current Ratio of 1.41 indicates that ASA should not have too much problems paying its short term obligations.
The Current ratio of ASA (1.41) is comparable to the rest of the industry.
A Quick Ratio of 1.16 indicates that ASA should not have too much problems paying its short term obligations.
ASA's Quick ratio of 1.16 is fine compared to the rest of the industry. ASA outperforms 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.41
Quick Ratio 1.16
ASA.OL Yearly Current Assets VS Current LiabilitesASA.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M 50M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 21.82% over the past year.
Looking at the last year, ASA shows a decrease in Revenue. The Revenue has decreased by -1.16% in the last year.
ASA shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 96.31% yearly.
EPS 1Y (TTM)21.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.66%
Revenue 1Y (TTM)-1.16%
Revenue growth 3Y30.69%
Revenue growth 5Y96.31%
Sales Q2Q%38.94%

3.2 Future

The Earnings Per Share is expected to grow by 55.10% on average over the next years. This is a very strong growth
ASA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.71% yearly.
EPS Next Y-222.8%
EPS Next 2Y43.37%
EPS Next 3Y55.1%
EPS Next 5YN/A
Revenue Next Year34.06%
Revenue Next 2Y68.26%
Revenue Next 3Y57.65%
Revenue Next 5Y22.71%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ASA.OL Yearly Revenue VS EstimatesASA.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M
ASA.OL Yearly EPS VS EstimatesASA.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -50 -100 -150 -200 -250

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ASA. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 4.02, the valuation of ASA can be described as very cheap.
Based on the Price/Forward Earnings ratio, ASA is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of ASA to the average of the S&P500 Index (92.74), we can say ASA is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 4.02
ASA.OL Price Earnings VS Forward Price EarningsASA.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ASA.OL Per share dataASA.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2

4.3 Compensation for Growth

ASA's earnings are expected to grow with 55.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.37%
EPS Next 3Y55.1%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ASA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ATLANTIC SAPPHIRE ASA

OSL:ASA (2/4/2025, 7:00:00 PM)

12.298

-0.4 (-3.17%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)08-20 2024-08-20
Earnings (Next)N/A N/A
Inst Owners0.34%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap88.19B
Analysts46.67
Price Target627.82 (5005.06%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)19899.7%
PT rev (3m)19899.7%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-19874.1%
EPS NY rev (3m)-2825.41%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.02
P/S 453.85
P/FCF N/A
P/OCF N/A
P/B 29.37
P/tB 29.37
EV/EBITDA N/A
EPS(TTM)-3.72
EYN/A
EPS(NY)3.06
Fwd EY24.9%
FCF(TTM)-0.15
FCFYN/A
OCF(TTM)-0.13
OCFYN/A
SpS0.03
BVpS0.42
TBVpS0.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -41.83%
ROE -51.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 82.96%
Cap/Sales 70.39%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.41
Quick Ratio 1.16
Altman-Z 70.38
F-Score3
WACC8.26%
ROIC/WACCN/A
Cap/Depr(3y)308.07%
Cap/Depr(5y)1123.22%
Cap/Sales(3y)260.86%
Cap/Sales(5y)664.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.66%
EPS Next Y-222.8%
EPS Next 2Y43.37%
EPS Next 3Y55.1%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.16%
Revenue growth 3Y30.69%
Revenue growth 5Y96.31%
Sales Q2Q%38.94%
Revenue Next Year34.06%
Revenue Next 2Y68.26%
Revenue Next 3Y57.65%
Revenue Next 5Y22.71%
EBIT growth 1Y-2.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year41.76%
EBIT Next 3Y46.72%
EBIT Next 5Y25.94%
FCF growth 1Y14.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-104.37%
OCF growth 3YN/A
OCF growth 5YN/A